Author:
Dobrodeeva L. K.,Samodova A. V.,Karyakina O. E.
Subject
Physiology (medical),Physiology
Reference95 articles.
1. National recommendations NSSC and SSCI for diagnosis and treatment of chronic heart failure, Konferentsiya Serdechnaya nedostatochnost’ (Conf. Heart Failure), 2010, vol. 1, p. 3.
2. Bazzino, O., Furreni, J.J., Botto, F., et al., PACS group of investigators. Relative value of N-terminal probrain natri-uretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes, Eur. Heart J., 2004, vol. 25, no. 10, p. 859.
3. Galvani, M., Ferrini, D., and Ottani, F., Natriuretic peptides for risk stratification of patients with acute coronary syndromes, Eur. J. Heart Failure, 2004, vol. 6, no. 3, p. 327.
4. Heeschen, C., Hamm, C.W., et al., N-terminal pro-BT natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes, Circulation, 2004, vol. 110, no. 20, p. 3206.
5. Smith, S.J., Bos, G., Essevitd, M.R., et al., Acutephase proteins from the liver and enzymes from myocardial infarction, a quantitative relationship, Clin. Chim. Acta, 1977, vol. 81, no. 1, p. 75.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献